共 50 条
- [31] Rationale and Design of a Phase 3b Multicenter, Randomized, Double-Blind Placebo-Controlled, Parallel-Group Trial with an Open-Label Extension Phase to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Pediatric Patients with Immune ThrombocytopeniaBLOOD, 2021, 138Grace, Rachael F.Xue, XiaoqiangJamieson, Brian
- [32] Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study)DIABETES OBESITY & METABOLISM, 2023, : 3632 - 3647Kimura, TomohikoKatakura, YukinoShimoda, MasashiKawasaki, FumikoYamabe, MizuhoTatsumi, FuminoriMatsuki, MichihiroIwamoto, YuichiroAnno, TakatoshiFushimi, YoshiroKamei, ShinjiKimura, YukikoNakanishi, ShuheiMune, TomoatsuKaku, KoheiKaneto, Hideaki
- [33] Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin An active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetesDIABETES CARE, 2013, 36 (12) : 4015 - 4021Ferrannini, EleBerk, AndreasHantel, StefanPinnetti, SabineHach, ThomasWoerle, Hans J.Broedl, Uli C.
- [34] Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled TrialDIABETES METABOLIC SYNDROME AND OBESITY, 2021, 14 : 1243 - 1252Zhang, FangTang, LizhiLi, JingYan, ZheLi, JuanTong, Nanwei
- [35] Efficacy and safety of Peginterferon alfa-2b (40 kD, Y Shape) (Pegberon) in HBeAg-positive CHB patients - a phase III, randomized, multi-center, positive-controlled, open-label clinical studyJOURNAL OF VIRAL HEPATITIS, 2015, 22 : 48 - 48Wang, G-QHou, F-QLv, W.Shang, J.Gong, G-ZPan, C.Zhang, M-XYin, C-BXie, Q.Peng, Y-ZChen, S-JMao, Q.Chen, Y-PMao, Q-GZhang, D-ZHan, T.
- [37] Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trialLANCET GLOBAL HEALTH, 2021, 9 (02): : E189 - E198Vanobberghen, FionaLweno, OmarKuemmerle, AndreaMwebi, Kwaba DennisAsilia, PeterIssa, AminaSimon, BeatusMswata, SarahSchmidlin, SandroGlass, Tracy R.Abdulla, SalimDaubenberger, ClaudiaTanner, MarcelMeyer-Monard, Sandrine
- [38] Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trialINTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (09)Hwang, You-CheolYoon, Kun-HoCha, Bong-SooLee, Kwan-WooJang, Hak ChulMin, Kyung WanChung, Choon HeeLee, Moon-Kyu
- [39] Efficacy and Safety of Peginterferon alfa-2b (40kD, Y Shape) (Pegberon) in HBeAg-positive CHB Patients - A Phase III, Randomized, Multi-center, Positive-Controlled, Open-label Clinical StudyHEPATOLOGY, 2015, 62 : 1195A - 1195AWang, Gui-QiangHou, Feng-QinLu, WeiShang, JiaGong, Guo-ZhongPan, ChenZhang, Ming-XiangYin, Chi-BiaoXie, QingPeng, Yan-ZhongChen, Shi-Jun
- [40] A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Safety Profile of a Needle-Free Insulin Injector with Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes MellitusDIABETES, 2019, 68Chen, LimingJi, LinongWang, YangangMa, ZhongshuRan, XingwuSun, ZilinXu, XiangjinWang, GuixiaGuo, LixinShan, Zhongyan